PD-L1 inhibitors in the pipeline: Promise and progress

by Vanella, Vito, Festino, Lucia, Strudel, Martina, Simeone, Ester, Grimaldi, Antonio M., Ascierto, Paolo A.
Published in Oncoimmunology (2017)

Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management

by Simeone, Ester, Grimaldi, Antonio M, Festino, Lucia, Trojaniello, Claudia, Vitale, Maria G, Vanella, Vito, Palla, Marco, Ascierto, Paolo A
Published in Melanoma Manag (2019)

Critical appraisal of the use of regorafenib in the management of colorectal cancer

by Festino, Lucia, Fabozzi, Alessio, Manzo, Anna, Gambardella, Valentina, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Ciardiello, Fortunato, Morgillo, Floriana
Published 2013

Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma: a case series

by Carlino, Matteo S, Vanella, Vito, Girgis, Christina, Giannarelli, Diana, Guminski, Alex, Festino, Lucia, Kefford, Richard F, Menzies, Alexander M, Long, Georgina V, Ascierto, Paolo A
Published in Br J Cancer (2016)

Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma

by Simeone, Ester, Grimaldi, Antonio Maria, Festino, Lucia, Giannarelli, Diana, Vanella, Vito, Palla, Marco, Curvietto, Marcello, Esposito, Assunta, Palmieri, Giuseppe, Mozzillo, Nicola, Ascierto, Paolo Antonio
Published in Oncoimmunology (2017)

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients

by Grimaldi, Antonio Maria, Simeone, Ester, Festino, Lucia, Giannarelli, Diana, Palla, Marco, Caracò, Corrado, Curvietto, Marcello, Esposito, Assunta, Grimaldi, Maria Chiara, Mozzillo, Nicola, Ascierto, Paolo A
Published in J Immunother Cancer (2015)

Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis

by Di Monta, Gianluca, Caracò, Corrado, Simeone, Ester, Grimaldi, Antonio Maria, Marone, Ugo, Di Marzo, Massimiliano, Vanella, Vito, Festino, Lucia, Palla, Marco, Mori, Stefano, Mozzillo, Nicola, Ascierto, Paolo Antonio
Published in J Transl Med (2017)

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

by Capone, Mariaelena, Giannarelli, Diana, Mallardo, Domenico, Madonna, Gabriele, Festino, Lucia, Grimaldi, Antonio Maria, Vanella, Vito, Simeone, Ester, Paone, Miriam, Palmieri, Giuseppe, Cavalcanti, Ernesta, Caracò, Corrado, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2018)

Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients

by Simeone, Ester, Grimaldi, Antonio Maria, Festino, Lucia, Giannarelli, Diana, Palla, Marco, Caracò, Corrado, Curvietto, Marcello, Esposito, Assunta, Paone, Miriam, Rinaldi, Giovanni, Grimaldi, Maria Chiara, Mozzillo, Nicola, Ascierto, Paolo A
Published in J Immunother Cancer (2015)

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

by Mozzillo, Nicola, Simeone, Ester, Benedetto, Lucia, Curvietto, Marcello, Giannarelli, Diana, Gentilcore, Giusy, Camerlingo, Rosa, Capone, Mariaelena, Madonna, Gabriele, Festino, Lucia, Caracò, Corrado, Di Monta, Gianluca, Marone, Ugo, Di Marzo, Massimiliano, Grimaldi, Antonio M, Mori, Stefano, Ciliberto, Gennaro, Ascierto, Paolo A
Published in Oncoimmunology (2015)

Ipilimumab and Stereotactic Radiosurgery with CyberKnife(®) System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience

by Borzillo, Valentina, Di Franco, Rossella, Giannarelli, Diana, Cammarota, Fabrizio, Scipilliti, Esmeralda, D’Ippolito, Emma, Petito, Angela, Serra, Marcello, Falivene, Sara, Grimaldi, Antonio M., Simeone, Ester, Festino, Lucia, Vanella, Vito, Trojaniello, Claudia, Vitale, Maria Grazia, Madonna, Gabriele, Ascierto, Paolo A., Muto, Paolo
Published in Cancers (Basel) (2021)

High expression of a spliced variant of FKBP51 in peripheral blood mononuclear cells of melanoma patients may be related to PDL-1 on tumour and predictive of response to Ipilimumab

by Simeone, Ester, Romano, Maria fiammetta, Grimaldi, Antonio Maria, Esposito, Assunta, Curvietto, Marcello, Paone, Miriam, Rinaldi, Giovanni, Di monta, Gianluca, Di marzo, Massimiliano, Hauber, Federica, Festino, Lucia, D'Angelillo, Anna, Romano, Simona, Staibano, Stefania, Ilardi, Gennaro, Bisogni, Rita, Mozzillo, Nicola, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2014)

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

by Turiello, Roberta, Capone, Mariaelena, Giannarelli, Diana, Morretta, Elva, Monti, Maria Chiara, Madonna, Gabriele, Mallardo, Domenico, Festino, Lucia, Azzaro, Rosa, Levesque, Mitchell P, Imhof, Laurence, Weide, Benjamin, Amaral, Teresa, Chevrier, Marc, Sucker, Antje, Rutkowski, Piotr, Schadendorf, Dirk, Lebbe, Celeste, Luke, Jason John, Wistuba-Hamprecht, Kilian, Dummer, Reinhard, Pinto, Aldo, Morello, Silvana, Ascierto, Paolo A
Published in J Immunother Cancer (2020)